Financials
Financial year 2025
Merck Chemicals NV/SA from Hoeilaart, company number BE0408308434, closed financial year 2025 with a result of € 112,404 after tax. For that financial year Merck Chemicals NV/SA recorded revenue of € 2.2 million and equity of € 71.1 million. Compared with financial year 2024, the result moved from € 15.3 million to € 112,404. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ 71.1 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 112,404
▼ 99% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 65.3 million.
People and assets in 2025
9.6
▲ 1.9 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 3 million
▲ 119% vs 2024
€ 312,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 92,727
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 219,851
▲ 164% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 41 days on average.
€ 276,864
▼ 4% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 4,007,181 | € 3,043,563 | € 3,479,871 | € 2,151,324 | ▼ 38% |
| Profit after taxes | € 45,003,650 | € 13,066,771 | € 15,275,752 | € 112,404 | ▼ 99% |
| Equity | € 69,330,977 | € 69,197,748 | € 70,973,500 | € 71,085,904 | |
| Total debts | € 742,867 | € 323,113 | € 13,873,905 | € 499,132 | ▼ 96% |
| Retained profit | € 63,568,977 | € 63,435,748 | € 65,211,500 | € 65,323,904 | |
| Dividend | € 0 | € 13,200,000 | € 13,500,000 | € 0 | ▼ 100% |
| Balance sheet total | € 70,073,844 | € 69,520,861 | € 84,847,405 | € 71,585,036 | ▼ 16% |
| Employees (FTE) | 6.4 | 7.6 | 7.7 | 9.6 | ▲ 1.9 |
Key figures of Merck Chemicals NV/SA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Merck Chemicals NV/SA?
What happened at Merck Chemicals NV/SA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Spasena Ivanova Yotova stepped down as director. NBB
- Susan King-Barnardo stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 112,404 (▼ 99% vs 2024). Source: NBB ↗
- Susan King-Barnardo became a director. NBB
- Benoit ELICHABE stepped down as director. NBB
- Spasena Ivanova Yotova became a director. NBB
- Benoit ELICHABE became a director. NBB
- New establishment in Hoeilaart. KBO
In short
From € 45 million profit in 2022 to € 112,404 profit in 2025.
Paid € 419,315 in corporate taxes since 2022.
Best year ever: 2022, with € 45 million profit.
Paid out € 26.7 million in dividends to the owners in total.
A new publication or filing at Merck Chemicals NV/SA? We notify you, reason included.
Follow Merck Chemicals NV/SADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Merck Chemicals B.V. Netherlands (100%) and Millipore S.A.S. (0%). It owns 100% of Merck Life Science itself.
Directors
According to the 2025 annual accounts
Benoit ELICHABE
Director
since 2021 · until 2026
since 2026 · until 2026
since 2025 · until 2030
Shareholders
Merck Chemicals B.V. Netherlands
100%
Participations
100%
Establishments
Establishment units
Physical locations of this company
Ildefonse Vandammestraat 5/7B
1560 Hoeilaart
Ildefonse Vandammestraat 5/7 box B
1560 Hoeilaart
Active since 23 May 2002
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0408.308.434
- VAT number
- BE 0408.308.434
- Registered office
- Ildefonse Vandammestraat 5/7B, 1560 Hoeilaart
- Names & denominations
- Merck Chemicals NV/SA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 19 May 1971
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Overige technische testen en toetsen
Technische testen en analyses
Vervaardiging van filtreertoestellen